Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of BAY94-9027 for Prophylaxis and Treatment of Bleeding in Previously Treated Children (Age <12 Years) With Severe Hemophilia A

NCT01775618 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01775618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01775618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of BAY94-9027 for Prophylaxis and Treatment of Bleeding in Previously Treated Children (Age <12 Years) With Severe Hemophilia A
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
May 29, 2013
Completion date
February 19, 2020
Enrollment
73 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a